P. Bakke (Bergen, Norway), A. Lindberg (Lulea, Sweden)
LATE-BREAKING ABSTRACT: COPD prevalence in Romania and possible influence of social and household characteristics
F. D. Mihaltan, F. Furtunescu, R. M. Nemes, D. Farcasanu, I. M. Daramus (Bucharest, Romania)
|   |
High prevalence of COPD symptoms in the Tunisian population contrasting with low awareness of the disease
M. Denguezli, H. Daldoul, L. Gnatiuc, A. Jithoo, S. Coton, B. Kato, Z. Boukheroufa, H. Azhar, I. Harrabi, P. Burney, Z. Tabka (Gafsa, Sousse, Tunisia; , ; London, United Kingdom)
| |
Low prevalence and severity of COPD in the Canary Islands: A temperate climate effect?
C. Cabrera-Lopez, C. Cabrera-Lacalzada, A. Martin-Medina, G. Julia-Serda, P. Cabrera-Navarro (Las Palmas de Gran Canaria, San Cristobal de La Laguna, Spain)
| |
Prevalence of COPD by disease severity in men and women in relation to smoking in northern Vietnam
H.T. Lâm, L. Ekerljung, N.V. Doàn, N.V. Tuong, E. Rönmark, K. Larsson, B. Lundbäck (Hanoi, Viet Nam; Stockholm, Gothenburg, Lulea, Sweden)
| |
Prevalence characteristics of COPD in never smokers
R. Bakr, I. Elmahallawy (Shebin Elkom, Egypt)
| |
Higher than expected prevalence of alpha-1-antitrypsin deficiency (AATD) may not necessarily impact on airflow, gas exchange or acute exacerbation rate (AER)
R. Dandurand, J. Bourbeau, D. Eidelman (Montreal, Canada)
| |
A new paradigm for classification of disease severity and progression of COPD
D. Mannino, E. Diaz-Guzman, J. Pospisil (Lexington, United States Of America)
| |
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
A. Cortot, I. Tillie-Leblond, F. Masure, B. Housset, N. Roche, T. Perez, I. Boucot, F. Denis, A. Myftiu, J. Ostinelli, I. Pithois-Merli, C. Pribil, S. Schück, A. Lallemand (Lille, Reims, Créteil, Paris, Marly Le Roi, Rueil-Malmaison, France)
| |
Distribution of a COPD population based on the GOLD assessment framework
G. Nadeau, P.W. Jones, L. Adamek, M. Small (Uxbridge, , Macclesfield, United Kingdom)
| |
Stability of COPD phenotypes over time
J. Garcia-Aymerich, M. Benet, J.M. Antó, the PAC-COPD Research Group (Barcelona, Spain)
| |
Characterisation of patients with COPD in Scotland
J. Covvey, B. Johnston, A. Boyter (Glasgow, United Kingdom)
| |
Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
T. Knight, X. Xu, R. Baik, X. Tu, J. Parker, N. Molfino (Gaithersburg, United States Of America)
| |
Recent trends of hospital admission characteristics for COPD and asthma in England from 1998 to 2011
I. Shiue (Truro, United Kingdom)
| |
COPD subtypes most likely to benefit from inhaled corticosteroids (ICS): Cluster analysis
R. DiSantostefano, H. Li, D. Rubin, D. Stempel (Research Triangle Park, United States Of America)
| |
Association between serum clara cell secretory protein (CC-16) levels and asthma-related phenotypes among adults from the EGEA study
M. Rava, N. Le Moual, X. Dumont, S. Guerra, V. Siroux, B. Jacquemin, A. Bernard, F. Kauffmann, R. Nadif (Villejuif, Grenoble, France; Brussels, Belgium; Barcelona, Spain)
| |
Obstructive airways diseases (OADs) are the most common diseases for a doctor visit in India: A one-day point-prevalence study in 2,04,912 patients from 880 cities and towns in India
K. Apte, M. Barne, S. Madas, J. Gogtay, S. Chhowala, N. Mahajan, S. Salvi (Pune, Mumbai, India)
| |
Time trends (1985-2011) in asthma and rhinitis in Italian general population samples
S. Cerrai, S. Maio, G. Sarno, S. Baldacci, M. Simoni, A. Angino, F. Martini, P. Silvi, M. Borbotti, G. Viegi (Pisa, Palermo, Italy)
| |
The prescribing patterns for asthma in general practice setting: Adherence to GINA guidelines
G. Sarno, S. Baldacci, S. Maio, A. Angino, F. Martini, S. Cerrai, M. Simoni, P. Silvi, M. Borbotti, A.P. Pala, M. Bresciani, G. Viegi (Pisa, Palermo, Italy)
| |